New Medications for Neuropsychiatric Disorders
June 3, 2020
Presenter:
Harika Reddy, MD|PGY-1
UC Riverside School of Medicine
Department of Psychiatry and Neuroscience
Co-presenter information:
Gerald A. Maguire, MD
Professor and Chair, Psychiatry and Neuroscience
University of California, Riverside School of Medicine
Chair, National Stuttering Association
Target Audience
This activity was developed for physicians along with nurses and ancillary staff.
Learning Objectives
At the end of this presentation, participants should be better able to:
- Summarize latest developments for bipolar disorder and schizophrenia
- Describe novel mechanisms of antidepressant therapy
- Discuss medications for indications that currently lack FDA approval
University of California School of Medicine at Riverside
Riverside, CA
92521
United States
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance